SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K was filed on August 28, 2014, reporting events occurring on August 25, 2014. The registrant, India Globalization Capital, Inc., is a Maryland corporation headquartered in Bethesda, Maryland. The filing addresses the status of the Company's 2014 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary event reported is the adjournment of the 2014 Annual Meeting of Stockholders. The meeting, originally scheduled for August 25, 2014, was adjourned due to a lack of quorum. It has been rescheduled for September 12, 2014, at 11:00 a.m. Eastern Standard Time, to be held at 11480 Commerce Park Drive, Suite 100, Reston, VA 20191.
Outlook, Risks, and Management Commentary
- Management Action: The Company will continue to solicit proxies from stockholders during the adjournment period to ensure a quorum is achieved for the reconvened meeting.
- Voting Instructions: Stockholders who have already voted do not need to recast their votes; previously submitted proxies will remain valid unless properly revoked.
- Deadline: The Company encourages stockholders who have not yet voted to do so by September 11, 2014, at 11:59 p.m. Eastern Standard Time.
- Risks/Contingencies: The filing does not disclose new material risks or contingencies beyond the procedural delay of the shareholder meeting.
Key Facts for Investor Verification
- Verify the date and location of the reconvened Annual Meeting (September 12, 2014, Reston, VA).
- Confirm whether previously submitted proxy votes remain valid for the adjourned meeting.
- Review the attached press release (Exhibit 99.1) for additional details on the proposals to be voted upon.
- Note that this filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.